Tech Company Financing Transactions
VentiRx Pharmaceuticals Funding Round
VentiRx Pharmaceuticals, based in Seattle, received $25 million in investment from MedImmune Ventures, Arch Venture Partners and Domain Associates.
Transaction Overview
MedImmune Ventures (Lead Investor) (Flanagan LeFlore)
Arch Venture Partners (Steven Gillis)
Domain Associates (Nicole Vitullo)
Frazier Healthcare Partners (Patrick Heron)
Company Information
Seattle, WA 98101
USA
Management Team
Browse more venture capital transactions:
Prev: 1/12/2010: Flurry venture capital transaction
Next: 1/12/2010: Molecular Biometrics venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs